- Live market news
- Stocks
- MMED
MiniMed Group, Inc. Common Stock
MMEDStockUSA
MiniMed Group, Inc. Common Stock
The MiniMed 780G is an insulin pump manufactured by Medtronic for patients with diabetes mellitus. The pump operates with a single AA battery and uses a piston-plunger pump to infuse a programmed amount of insulin into the patient through a length of tubing. The 780G uses a one-way wireless radio frequency link to receive blood sugar measurements from the patient's continuous glucose monitor. The 780G is capable of automated insulin delivery with a closed-loop control algorithm branded as SmartGuard.
Key figures
- Previous close
- 19.29
- Open
- 19.63
- Day range
- 17.75 – 19.63
- 52-week range
- —
- Volume
- 9.56M
Latest news on MMEDranked by Oyticker for market impact
- 45Impact
MiniMed Smart MDI alert responsiveness linked to improved glucose control in type 1 diabetes
MiniMed presented clinical evidence that higher frequency of user responses to Smart MDI alerts correlates with better glucose outcomes in type 1 diabetes patients. The finding supports the value proposition of alert-driven insulin management technology.
MMEDMedical DevicesHealthcare TechnologyDiabetes Care - 15Impact
MiniMed appoints Sheila Denton as General Counsel & Corporate Secretary
MiniMed announced the appointment of Sheila Denton to the role of General Counsel & Corporate Secretary, a routine executive staffing decision.
MMEDMedical DevicesHealthcare Technology
In detailthe same figures as in Oyticker Charts
Performance
Ranges & volume
- Open
- 19.63
- Prev. close
- 19.29
Risk · 1 year
Seasonality
What MMED filed
- 16 Oct 2026
Executive or director change · Investor communication
- 13 Oct 2026
- 8 Sept 2026
- 1 Sept 2026
Investor communication
- 21 Aug 2026
- 5 Aug 2026
- 29 Jun 2026
- 29 Jun 2026
- 3 Jun 2026
Investor communication
- 18 May 2026
From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.
Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.